Lianmin Wang - Publications

O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 16, 2024

METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells.

Journal: Discover oncology

Published: December 14, 2024

Inhibition of miR-155 attenuates dendritic cell maturation and skin allograft rejection through SOCS1 in a rhesus monkey model.

Journal: Central-European journal of immunology

Published: July 31, 2024

HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 05, 2022

Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma.

Journal: BMC medical genomics

Published: May 04, 2022

Local application of triamcinolone acetonide-conjugated chitosan membrane to prevent benign biliary stricture.

Journal: Drug delivery and translational research

Published: March 25, 2022

A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.

Journal: Journal of cancer research and therapeutics

Published: July 05, 2018

Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor.

Journal: International journal of oncology

Published: January 18, 2016